Antinuclear autoantibodies in blood donors and patients without symptoms of collagenosis

Radoslaw Spiewak, Nimfa Maria Stojek, Katarzyna Curzytek

Sensimun, Krakow, Poland, and Institute of Agricultural Medicine, Lublin, Poland

Source: Spiewak R, Stojek NM, Curzytek K. Antinuclear autoantibodies in blood donors and patients without symptoms of collagenosis. J Physiol Pharmacol 2007; 58 (Suppl 4: First International Conference "Medical Biology and Human Life"): 84.

Introduction: Antinuclear antibodies (ANA) are antibodies directed against nuclear structures of body's own cells. The causal and diagnostic role of ANA in autoimmune diseases - collagenoses, is vividly discussed.

Aims: To assess the frequency of antinuclear antibodies in samples of Polish general population.

Material and methods: Two groups were studied: "BD" - 50 blood donors (all males aged 21-55 years) from a donation centre in Lublin, and "PT" - 50 unselected patients from a rural health centre (42 females and 8 males aged 21-65, none was suspected of having an autoimmune/rheumatic disease). Sera of these persons were tested for the presence of ANA. Enzyme-linked immunoassay (ELISA) was used with the Varelisa ReCombi ANA Profile EIA kit (Pharmacia&Upjohn). ReCombi ANA Profile contained the following antigens: dsDNA, RNP, Sm, SS-A/Ro, SS-B/La, Scl-70, CENP, Jo-1.

Results: One or more antinuclear autoantibodies were detected in 6 of 50 donors, and in 11 of 50 patients; dsDNA-specific autoantibodies were found in 1 donor and 5 patients, RNP - in 1 donor and 1 patient, SS-A/Ro - in 4 donors and 4 patients, SS-B/La - in no donor and 2 patients, Scl-70 - in 1 donor and 2 patients, Jo-1 - in no donor but in 2 patients. No Sm and CENP-specific autoantibodies were detected. There were no significant differences between blood donors and patients.

Conclusions: Altogether, antinuclear autoantibodies were found in 17 of 100 persons without signs of an autoimmune diseases, which suggests an appropriate caution when interpreting test results indicating the presence of ANA in a patient.

Related articles:

  1. Spiewak R, Stojek NM. Antinuclear antibodies among eastern-Polish rural inhabitants. Ann Agric Environ Med 2003, 10 (2): 207-209.
  2. Spiewak R, Stojek NM, Chmielewska-Badora J. Antinuclear antibodies are not increased in the early phase of Borrelia infection. Ann Agric Environ Med 2004, 11 (1): 145-148.


Institute of Dermatology, Krakow, Poland

Sensimun Biomedical Research - outsourcing in allergy and immunology research

ELISpot - training, implementation, outsourcing

English-speaking dermatologist in Krakow (Cracow), Poland

Deutschsprechender Hautarzt in Krakow (Krakau), Polen

© Radoslaw Spiewak (contact).
This page is part of the website.
Document created: 17 October 2008, last updated: 4 July 2010.